Calamos Advisors
CDLX icon

Calamos Advisors’s Cardlytics CDLX Stock Holding History

Calamos Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,195
Closed -$1.52M – 995
2021
Q2 		$1.52M Sell
1,195
-3,054
-72% -$3.45M 0.01% 762
2021
Q1 		$4.66M Sell
4,249
-2,117
-33% -$2.8M 0.03% 551
2020
Q4 		$9.09M Buy
6,366
+914
+17% +$975K 0.05% 357
2020
Q3 		$3.85M Buy
5,452
+101
+2% +$73.4K 0.02% 498
2020
Q2 		$3.75M Buy
5,351
+1,869
+54% +$1.08M 0.03% 503
2020
Q1 		$1.22M Sell
3,482
-1,932
-36% -$1.37M 0.01% 580
2019
Q4 		$3.4M Buy
+5,414
New +$2.65M 0.02% 567

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Calamos Advisors's CDLX Position: Q3 2021 in Review

Calamos Advisors sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 1,195 shares — an estimated $1.52M sold.

Calamos Advisors first reported a position in CDLX in Q4 2019 and held it in 7 quarters. The position peaked at $9.09M in Q4 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Calamos Advisors reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Calamos Advisors sold 1,195 Cardlytics shares in Q3 2021, an estimated $1.52M.
  • Calamos Advisors first reported a position in Cardlytics in Q4 2019 and held it in 7 quarters.
  • Calamos Advisors's Cardlytics position peaked at $9.09M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.